Novel beta-galactoside-alpha2,3-sialyltransferase, gene encoding the same, and process for production of the same

Details for Australian Patent Application No. 2006238137 (hide)

International Classifications

Event Publications

6 December 2007 PCT application entered the National Phase

PCT publication WO2006/112253 Priority application(s): WO2006/112253

10 February 2011 Application Accepted

Published as AU-B-2006238137

26 May 2011 Application for Amendment

The nature of the amendment is: Amend the invention title to read A novel beta-galactoside-alpha2,3-sialyltransferase, a gene encoding thereof and a method for producing thereof. Address for service in Australia - Griffith Hack Level 29, Northpoint 100 Miller Street North Sydney NSW 2060

15 September 2011 Amendment Made

The nature of the amendment is: Amend the invention title to read A novel beta-galactoside-alpha2,3-sialyltransferase, a gene encoding thereof and a method for producing thereof 2006269350 Eveready Battery Company, Inc. The nature of the amendment is as shown in the statement(s) filed 21 Apr 2011 2007

22 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.